Cargando…
Molecular subtyping of hepatocellular carcinoma: A step toward precision medicine
Hepatocellular carcinoma (HCC) is one of the most prevalent and fatal digestive tumors. Treatment for this disease has been constraint by heterogeneity of this group of tumors, which has greatly limited the progress in personalized therapy. Although existing studies have revealed the genetic and epi...
Autores principales: | Wu, Yichao, Liu, Zhikun, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743018/ https://www.ncbi.nlm.nih.gov/pubmed/33290597 http://dx.doi.org/10.1002/cac2.12115 |
Ejemplares similares
-
Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021) -
The clinical value of quantitative cardiovascular molecular imaging: a step towards precision medicine
por: Tingen, Hendrea Sanne Aletta, et al.
Publicado: (2023) -
Genetic Biomarkers For Hepatocellular Carcinoma In The Era Of Precision Medicine
por: Duan, Jingxian, et al.
Publicado: (2019) -
Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma
por: Šamec, Neja, et al.
Publicado: (2020) -
Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective
por: Galun, Danijel, et al.
Publicado: (2022)